Clinical Trials Directory

Trials / Completed

CompletedNCT03348709

Osmolality of Oral Supplements and Ileostomy Output

Does Osmolality of Oral Supplements Affect Stoma Output and Natriuresis in Patients With an Ileostomy?

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
8 (actual)
Sponsor
University of Aarhus · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This double-blinded, active comparator, cross-over intervention study tested the impact of two different oral supplements on ileostomy output volume and urinary sodium excretion and intestinal aquaporin expression in eight compensated patients with an ileostomy and not on home parenteral Nutrition or fluid support.

Detailed description

Patients with an ileostomy may experience fluid and electrolyte imbalances sedondary to an unregulated intestinal loss of water and electrolytes. The osmolality of oral supplements may affect these losses. In a double-blinded, active comparator, cross-over intervention study, the investigators test the effects of substituting 800 ml of the usual fluid intake with an intake of either an isoosmolar (300 mOsm/kg) or hyperosmolar (700 mOsm/kg) supplement during 48 hours, following baseline data collection before both intervention periods. Outcome measures were stoma output volume, 24-hour urine and urinary sodium excretion, and intestinal aquaporin 3 and 8 expressions.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTIsoosmolar48 hours, 800 ml per 24 hours
DIETARY_SUPPLEMENTHyperosmolar48 hours, 800 ml per 24 hours

Timeline

Start date
2017-06-01
Primary completion
2018-06-01
Completion
2018-11-01
First posted
2017-11-21
Last updated
2018-11-05

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03348709. Inclusion in this directory is not an endorsement.